​

IQVIA (IQV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IQV Stock Forecast

IQVIA (IQV) stock forecast, based on 45 Wall Street analysts, predicts a 12-month average price target of $284.64, with a high of $345.00 and a low of $240.00. This represents a 1.89% increase from the last price of $279.36.

$150 $190 $230 $270 $310 $350 High: $345 Avg: $284.64 Low: $240 Last Closed Price: $279.36

IQV Stock Rating

IQVIA stock's rating consensus is Buy, based on 45 Wall Street analysts. The breakdown includes 1 Strong Buy (2.22%), 36 Buy (80.00%), 7 Hold (15.56%), 1 Sell (2.22%), and 0 Strong Sell (0.00%).

Buy
Total 45 1 7 36 1 Strong Sell Sell Hold Buy Strong Buy

IQV Price Target Upside V Benchmarks

TypeNameUpside
StockIQVIA1.89%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks1.63%
IdeaSaaS Stocks List25.07%

Price Target Trends

1M3M12M
# Anlaysts5933
Avg Price Target$315.40$294.56$253.58
Last Closing Price$279.36$279.36$279.36
Upside/Downside12.90%5.44%-9.23%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 263163--22
Sep, 263153--21
Aug, 264152--21
Jul, 264153--22
Jun, 264172--23
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 14, 2026Stifel Nicolaus$303.00$260.7116.22%8.46%
Oct 07, 2026Mizuho Securities$300.00$260.1615.31%7.39%
Oct 07, 2026Luke SergottBarclays$300.00$260.1615.31%7.39%
Sep 30, 2026UBS$345.00$269.1928.16%23.50%
Sep 28, 2026Truist Financial$329.00$270.3721.69%17.77%
Sep 17, 2026Morgan Stanley$270.00$268.820.44%-3.35%
Jul 29, 2026RBC Capital$247.00$246.030.39%-11.58%
Jul 29, 2026Sean DodgeBMO Capital$270.00$249.518.21%-3.35%
Jul 29, 2026Eric ColdwellRobert W. Baird$287.00$243.3117.96%2.73%
Jul 13, 2026Ann HynesMizuho Securities$230.00$207.8510.66%-17.67%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 07, 2026BarclaysOverweightOverweighthold
Jul 29, 2026RBC CapitalOutperformOutperformhold
Jul 29, 2026Cowen & Co.BuyBuyhold
Jul 29, 2026BMO CapitalOutperformOutperformhold
Jul 28, 2026BarclaysOverweightOverweighthold
Jul 06, 2026HSBCBuyBuyhold
Jun 17, 2026Morgan StanleyOverweightEqual-Weightdowngrade
Jun 05, 2026RBC CapitalOutperformOutperformhold
Apr 08, 2026Evercore ISIOutperformOutperformhold
Mar 06, 2026BarclaysOverweightOverweightupgrade

Financial Forecast

EPS Forecast

$5 $8 $11 $14 $17 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.05$5.82$7.39$7.57$7.91---
Avg Forecast$8.91$10.15$10.19$11.12$11.92$13.28$14.73$16.44
High Forecast$9.08$10.36$10.21$11.17$12.16$15.49$16.25$16.73
Low Forecast$8.79$9.99$10.17$11.10$11.61$11.72$12.58$15.94
Surprise %-43.32%-42.66%-27.48%-31.92%-33.64%---

Revenue Forecast

$14B $15B $16B $17B $19B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.87B$14.41B$14.98B$15.40B$16.31B---
Avg Forecast$13.83B$14.38B$14.91B$15.38B$16.04B$17.01B$18.04B$19.49B
High Forecast$14.02B$14.61B$14.92B$15.39B$16.21B$17.01B$18.06B$19.76B
Low Forecast$13.68B$14.21B$14.90B$15.35B$15.68B$17.01B$18.02B$19.03B
Surprise %0.32%0.20%0.49%0.18%1.71%---

Net Income Forecast

$500M $1B $2B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$966.00M$1.09B$1.36B$1.37B$1.36B---
Avg Forecast$896.18M$1.17B$1.36B$2.07B$2.21B$2.54B$2.69B$3.06B
High Forecast$1.08B$1.41B$1.63B$2.08B$2.27B$2.89B$3.03B$3.12B
Low Forecast$716.94M$938.68M$1.09B$2.07B$2.16B$2.18B$2.34B$2.97B
Surprise %7.79%-7.02%--33.80%-38.57%---

IQV Forecast FAQ

Is IQVIA stock a buy?

IQVIA stock has a consensus rating of Buy, based on 45 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 36 Buy, 7 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that IQVIA is a favorable investment for most analysts.

What is IQVIA's price target?

IQVIA's price target, set by 45 Wall Street analysts, averages $284.64 over the next 12 months. The price target range spans from $240 at the low end to $345 at the high end, suggesting a potential 1.89% change from the previous closing price of $279.36.

How does IQVIA stock forecast compare to its benchmarks?

IQVIA's stock forecast shows a 1.89% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (1.63%), trailing the SaaS Stocks List (25.07%) investment idea.

What is the breakdown of analyst ratings for IQVIA over the past three months?

  • October 2026: 13.64% Strong Buy, 72.73% Buy, 13.64% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 19.05% Strong Buy, 71.43% Buy, 9.52% Hold, 0% Sell, 0% Strong Sell.

What is IQVIA’s EPS forecast?

IQVIA's average annual EPS forecast for its fiscal year ending in December 2026 is $13.28, marking a 67.89% increase from the reported $7.91 in 2025. Estimates for the following years are $14.73 in 2027, and $16.44 in 2028.

What is IQVIA’s revenue forecast?

IQVIA's average annual revenue forecast for its fiscal year ending in December 2026 is $17.01B, reflecting a 4.30% increase from the reported $16.31B in 2025. The forecast for 2027 is $18.04B, and $19.49B for 2028.

What is IQVIA’s net income forecast?

IQVIA's net income forecast for the fiscal year ending in December 2026 stands at $2.54B, representing an 86.43% increase from the reported $1.36B in 2025. Projections indicate $2.69B in 2027, and $3.06B in 2028.